Sponsor:
University Health Network, Toronto
Code:
NCT07945470
Conditions
Indolent B-Cell Non-Hodgkin Lymphoma
Marginal Zone Lymphoma
Follicular Lymphoma
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma (MCL)
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)
Brief summary:
Conditions
Indolent B-Cell Non-Hodgkin Lymphoma
Marginal Zone Lymphoma
Follicular Lymphoma
Small Lymphocytic Lymphoma
Mantle Cell Lymphoma (MCL)
Study ID
NCT07945470
Start date
Oct 9, 2026
Status verified date
Nov, 2026
Completion date
Dec 31, 2028
Anticipated
Primary completion date
Dec 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
60 participants
Anticipated
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Simulation-Free Single-Fraction Radiation Therapy
Interventions
Simulation-Free Single-Fraction Radiation Therapy (4 Gy × 1)
Primary outcome measure
Central contacts
Locations
Princess Margaret Cancer Centre, University Health Network
Recruiting
Toronto, Ontario, Canada, M5G 1X6
Contacts
Sponsor
University Health Network, Toronto
Last update posted
Nov 18, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by University Health Network, Toronto on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.